Saturday 17 October 2026
Export PRPH’s income statement to Excel — free account
ProPhase Labs, Inc.
PRPH Healthcare Diagnostics & Research
In the quarter to June 2026, revenue fell 18.9%, EPS grew 80.0%, free cash flow grew 56.7% and total debt rose 19.4%, each against the same quarter a year earlier.
0.01
0.00
0.00%
Follow PRPH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.85 | 0.00 | 0.00 | 0.00 | 17.93 | 7.98 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 6 | 4 | 4 | 3 | 6 | 7 | 1 | 1 | 4 |
P/S ratio |
8.24 | 3.53 | 2.73 | 2.31 | 7.33 | 1.38 | 1.24 | 2.28 | 2.25 | 0.88 |
Altman Z-Score |
0.46 | 12.90 | 6.58 | 13.75 | 3.51 | 4.03 | 6.90 | 0.99 | (3.07) | (3.59) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.05 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(4.66) | 24.87 | 8.71 | 13.95 | 1.71 | 6.21 | 8.38 | 1.40 | (7.14) | (11.41) |
P/Operating CF |
87.12 | (20.20) | (45.96) | (53.23) | (15.73) | (23.41) | 186.97 | (106.03) | (4.32) | (3.11) |
Beneish M-Score |
(3.21) | (1.32) | (3.31) | (3.06) | (4.60) | 3.42 | (2.87) | (1.35) | — | (4.90) |
P/B ratio |
5.82 | 1.09 | 2.18 | 2.03 | 10.08 | 1.86 | 2.38 | 1.62 | 2.07 | 1.09 |
Price to Tangible BV |
14.54 | 1.23 | 2.78 | 2.98 | 12.64 | 2.59 | 3.07 | 2.51 | 0.00 | 0.00 |
EV/Sales |
8.84 | 1.61 | 2.33 | 2.47 | 7.46 | 1.29 | 1.12 | 2.55 | 4.72 | 2.19 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.63 | 4.78 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(78.80) | (5.60) | (14.45) | (28.99) | (41.79) | (7.49) | 4.80 | (7.51) | (1.82) | (1.14) |
EV/FCF |
(33.12) | (5.22) | (0.71) | (22.81) | (49.23) | (3.79) | 5.46 | (6.41) | (1.76) | (1.16) |
Quick Ratio |
0.91 | 14.56 | 3.79 | 8.77 | 1.84 | 3.56 | 3.39 | 1.94 | 0.65 | 0.03 |
Current Ratio |
1.41 | 15.68 | 4.31 | 10.66 | 2.52 | 3.95 | 3.78 | 2.28 | 0.95 | 0.06 |
Net Debt/EBITDA |
(0.31) | 6.02 | 6.59 | 0.48 | (1.15) | (0.51) | (0.51) | (0.46) | (0.55) | (0.74) |
Debt/Assets |
11.64% | 0.00% | 0.00% | 0.00% | 32.86% | 11.99% | 3.08% | 12.43% | 27.61% | 9.68% |
Debt/Equity |
0.25 | 0.00 | 0.00 | 0.00 | 0.98 | 0.18 | 0.04 | 0.23 | 2.37 | 1.65 |
Asset Turnover |
0.30 | 0.42 | 0.48 | 0.60 | 0.66 | 1.31 | 1.39 | 0.39 | 0.09 | 0.07 |
Operating CF/Net income |
0.16 | (0.07) | 1.22 | 0.27 | 1.22 | (2.17) | 1.55 | 0.71 | 0.33 | 0.57 |
Capex/Depreciation |
(1.45) | (0.60) | (0.37) | (0.57) | 0.85 | (3.73) | (0.68) | (0.31) | (0.08) | 0.01 |
Interest Coverage |
(17.81) | (17.27) | (9.78) | (24.35) | (7.05) | 8.54 | 30.88 | (16.76) | (11.53) | (2.60) |
| (38.78%) | 214.71% | (7.20%) | (22.69%) | (19.51%) | 18.13% | 30.20% | (29.70%) | (188.11%) | (271.49%) | |
| (20.76%) | 174.72% | (6.40%) | (19.06%) | (9.73%) | 10.39% | 20.87% | (18.69%) | (68.80%) | (23.96%) | |
ROIC |
(33.82%) | (25.17%) | (12.36%) | (20.51%) | (10.47%) | 11.82% | 30.16% | (23.65%) | (100.08%) | (122.44%) |
Return on Tangible Assets |
(48.10%) | 138.31% | (10.54%) | (27.74%) | (16.13%) | 12.12% | 35.47% | (45.29%) | (888.81%) | 30.78% |
Average Days of Receivables |
500.73 | 164.43 | 216.84 | 252.13 | 79.34 | 174.13 | 110.27 | 373.66 | 1,081.41 | 129.03 |
Research and Development Expense of Revenue |
8.51% | 4.37% | 3.03% | 3.36% | 4.36% | 0.66% | 0.53% | 4.01% | 8.77% | 2.46% |
Selling, General and Administrative Expense of Revenue |
105.40% | 55.81% | 45.84% | 55.91% | 51.66% | 28.46% | 28.04% | 95.59% | 559.60% | 444.74% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.19 | 0.16 | 0.19 | 0.24 | 0.19 |
Share Based Compensation of Revenue |
0.02% | 0.79% | 4.83% | 7.53% | 10.05% | 4.03% | 3.25% | 10.11% | 53.74% | 43.57% |
Graham Net Nets |
0.08 | 0.76 | 0.39 | 0.39 | (0.05) | 0.28 | 0.24 | 0.06 | (1.66) | (13.93) |
Graham Number |
0.00 | 110.31 | 0.00 | 0.00 | 0.00 | 58.97 | 104.13 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(8.37%) | 118.00% | (4.71%) | (14.23%) | (2.05%) | 5.58% | 12.54% | (21.12%) | (313.56%) | (386.58%) |
Free Cash Flow Yield |
(3.24%) | (8.74%) | (120.04%) | (4.69%) | (2.07%) | (24.74%) | 16.54% | (17.44%) | (119.84%) | (215.29%) |
Revenue per Share |
2.46 | 6.34 | 11.52 | 8.54 | 12.52 | 52.10 | 77.40 | 20.33 | 3.39 | 0.51 |
Operating CF per Share |
(0.28) | (1.82) | (1.86) | (0.73) | (2.24) | (8.98) | 18.02 | (6.91) | (8.77) | (0.98) |
Capex per Share |
(0.38) | (0.13) | (0.12) | (0.20) | 0.34 | (8.76) | (2.19) | (1.18) | (0.34) | 0.01 |
Free Cash Flow per Share |
(0.66) | (1.96) | (1.98) | (0.92) | (1.90) | (17.74) | 15.83 | (8.09) | (9.11) | (0.97) |
Cash per Share |
0.26 | 14.09 | 7.23 | 1.18 | 7.29 | 11.54 | 11.00 | 2.75 | 0.34 | 0.01 |
Shareholders Equity per Share |
3.49 | 20.46 | 14.48 | 9.71 | 9.10 | 38.64 | 40.16 | 28.70 | 3.68 | 0.41 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.49 | 20.46 | 14.48 | 9.71 | 9.10 | 38.64 | 40.16 | 28.70 | 3.68 | 0.41 |
Free Cash Flow |
(1.12) | (3.05) | (2.26) | (1.07) | (2.20) | (26.92) | 25.08 | (13.93) | (18.21) | (8.22) |
Working Capital |
2.79 | 26.61 | 14.01 | 9.01 | 9.59 | 45.79 | 44.76 | 26.73 | (1.50) | (49.93) |
Capital Expenditures |
(0.65) | (0.21) | (0.14) | (0.23) | 0.39 | (13.30) | (3.47) | (2.04) | (0.68) | 0.12 |
Net Current Asset Value |
2.79 | 26.61 | 14.01 | 8.90 | (4.96) | 30.65 | 36.82 | 5.04 | (25.21) | (53.21) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.40 | 5.80 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.15 | 0.02 | 0.01 | 0.02 | (0.03) | 0.17 | 0.03 | 0.06 | 0.10 | (0.03) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.10 | 6.43 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.13 | 0.15 | 0.17 | 0.13 | 0.60 | 0.70 | 0.64 | 1.08 | 5.07 |
Cash ROIC |
(14.23%) | (5.66%) | (9.13%) | (8.49%) | (7.50%) | (30.99%) | 29.94% | (21.25%) | (71.48%) | (87.56%) |
Accounts Receivable Turnover |
0.86 | 1.93 | 2.14 | 1.35 | 2.91 | 3.87 | 3.28 | 0.96 | 0.24 | 0.40 |
Accounts Payable Turnover |
2.04 | 5.83 | 16.71 | 16.71 | 4.71 | 6.86 | 8.04 | 2.67 | 0.62 | 0.11 |
Inventory Turnover |
0.91 | 3.71 | 4.86 | 4.32 | 4.41 | 9.70 | 12.13 | 6.20 | 4.03 | 4.88 |
Average Days of Payables |
245.23 | 25.90 | 19.11 | 21.72 | 138.92 | 69.21 | 41.45 | 162.40 | 723.51 | 4,999.92 |
Days of Inventory on Hand |
311.20 | 70.57 | 83.23 | 73.34 | 111.95 | 45.31 | 27.91 | 43.04 | 60.29 | 8.63 |
Average Receivables |
4.89 | 5.11 | 6.12 | 7.31 | 4.99 | 20.43 | 37.38 | 36.43 | 27.94 | 10.80 |
Average Payables |
1.57 | 1.36 | 0.50 | 0.43 | 2.10 | 5.40 | 6.47 | 7.27 | 11.18 | 27.14 |
Average Inventory |
3.53 | 2.13 | 1.72 | 1.68 | 2.25 | 3.82 | 4.29 | 3.13 | 1.72 | 0.61 |
Average Assets |
13.82 | 23.23 | 27.20 | 16.51 | 21.84 | 60.35 | 88.47 | 89.79 | 77.56 | 61.54 |
Average Common Equity |
7.40 | 18.90 | 24.18 | 13.87 | 10.89 | 34.59 | 61.13 | 56.51 | 28.37 | 5.43 |
Columns are period end dates